Followers | 6 |
Posts | 2155 |
Boards Moderated | 0 |
Alias Born | 11/26/2014 |
Monday, April 24, 2017 2:38:27 PM
I use many factors to come up with my numbers. I take in all info and evaluate. Much more here than just my calculation:
1. Focalin 15 and 30mg is a $200M market. IPCI is getting 1% or $2M in annual revenue from those doses.
2. I am figuring Seroquel as a $700M dollar market. I believe the Seroquel deal is much better for IPCI. So I estimate they will obtain 2-2.5% of that entire market in revenue. 2% equates to $14M annually. 2.5% equates $17.5M annually. Thus, $3-4.5M
We also need to factor increased competition coming in later in 2017. My estimate is $3-4M but am thinking the number is closer to $3M. I have seen anywhere from $3-9M per quarter estimated. Those high estimates are way out of whack. I am conservatively estimating $1M per month or $3M per quarter. I do think it may be a little higher than that, but not by much.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM